 |
Insurers
hold key to diabetes device sales |
| |
Companies that make continuous glucose monitors
to help diabetics manage their blood sugar will see an upturn in
demand for the devices in the next few years as more private insurers
agree to pay for them (Reuters) |
| |
|
|
Long-Acting
Insulins in Type 1 Diabetes Safer Than Traditional Agents |
| |
For type 1 diabetes, long-acting insulins such
as glargine (Lantus) reduce severe hypoglycemic episodes but don't
offer clinically significant improved glycemic control, according
to a meta-analysis (Medpage Today) |
| |
|
|
Scientists
discover possible cause of circulatory complications of diabetes |
| |
Scientists at the University of Bristol have
identified a protein in cells that could be responsible for circulatory
complications of diabetes (JDRF) |
| |
|
|
Alcohol
consumption and risk of microvascular complications in type 1
diabetes patients: the EURODIAB Prospective Complications Study |
| |
Consistent with its effects on macrovascular
complications, moderate alcohol consumption is associated with
a lower risk of all microvascular complications among type 1 diabetes
patients (Diabetologia) |
| |
|
|
Investment
in Disease Prevention Could Save America More than $16 Billion
in Five Years |
| |
Return on investment of more than 5 to 1; focus
on increasing physical activity, improving nutrition (RWJF, USA) |
| |
|
